Table 5.
Characteristics | Death | Survival | Sensitivity, % (95% CI) | Specificity, % (95% CI) | FPR, % (95% CI) | PPV, % (95% CI) | NPV, % (95% CI) |
---|---|---|---|---|---|---|---|
BLS TOR rule | |||||||
The Group of 2015 | 851 | 32 | 86.7 (84.2–88.9) | 40.6 (24.2–52.9) | 59.4 (47.1–75.8) | 97.5 (96.0–98.4) | 10.3 (5.8–17.3) |
Met criteria | 738 | 19 | |||||
Not met criteria | 113 | 13 | |||||
The Group of 2020 | 546 | 26 | 78.8 (75.0–82.1) | 69.2 (48.1–84.9) | 30.8 (15.1–51.9) | 98.2 (96.3–99.1) | 13.4 (8.4–20.7) |
Met criteria | 430 | 8 | |||||
Not met criteria | 116 | 18 | |||||
ALS TOR rule | |||||||
The Group of 2015 | 353 | 24 | 34.6 (29.7–39.8) | 91.7 (71.5–98.5) | 8.3 (1.5–28.5) | 98.4 (93.7–99.7) | 8.7 (5.7–13.0) |
Met criteria | 122 | 2 | |||||
Not met criteria | 231 | 22 | |||||
The Group of 2020 | 383 | 24 | 27.2 (22.8–32.0) | 100.0 (82.8–100.0) | 0 (0.0–17.2) | 100.0 (95.6–100.0) | 7.9 (5.2–11.7) |
Met criteria | 104 | 0 | |||||
Not met criteria | 279 | 24 |
TOR Termination Of Resuscitation, CI Confidence Interval, FPR False-Positive Rate, PPV Positive Predictive Value, NPV Negative Predictive Value, BLS Basic Life Support, ALS Advanced Life Support